Helm
-
Helm acquires shares in Amarin
Helm has purchased a 30 percent shareholding in Amarin Technologies, a privately owned pharmaceutical development company in Buenos Aires, Argentina. Amarin has more than 20 years of experience in the technology of transdermal delivery systems an…
Helm | 09 February 2011
-
Richter-Helm BioLogics: Breakthrough in Purification of Antibody Fragments
Richter-Helm BioLogics has announced a technological breakthrough in the field of purification of antibody fragments from an E coli expression system. The company has finalized the downstream process for Phase III clinical trial material using Se…
Helm | 08 June 2009
